Kodiak Sciences (KOD) Stock Forecast, Price Target & Predictions

OverviewOwnership Financials Chart Transcripts

KOD Stock Forecast

Kodiak Sciences stock forecast is as follows: an average price target of $31.60 (represents a 471.43% upside from KOD’s last price of $5.53) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

KOD Price Target

The average price target for Kodiak Sciences (KOD) is $31.60 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $114.00 to $2.00. This represents a potential 471.43% upside from KOD's last price of $5.53.

KOD Analyst Ratings

Buy

According to 9 Wall Street analysts, Kodiak Sciences's rating consensus is 'Buy'. The analyst rating breakdown for KOD stock is 0 'Strong Buy' (0.00%), 4 'Buy' (44.44%), 3 'Hold' (33.33%), 2 'Sell' (22.22%), and 0 'Strong Sell' (0.00%).

Kodiak Sciences Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 24, 2024	Andrea Tan	Goldman Sachs	$2.00	$2.43	-17.78%	-63.83%
Nov 14, 2022	-	Morgan Stanley	$9.00	$7.59	18.58%	62.75%
Nov 10, 2022	-	Goldman Sachs	$8.00	$7.22	10.80%	44.67%
Aug 15, 2022	-	Morgan Stanley	$12.00	$11.73	2.30%	117.00%
Aug 10, 2022	-	Chardan Capital	$18.00	$11.84	52.03%	225.50%
Aug 09, 2022	-	Truist Financial	$15.00	$11.13	34.77%	171.25%
Aug 09, 2022	-	Goldman Sachs	$9.00	$11.55	-22.08%	62.75%
May 24, 2022	-	Goldman Sachs	$5.00	$6.55	-23.66%	-9.58%
May 11, 2022	-	Goldman Sachs	$7.00	$5.20	34.62%	26.58%
Feb 11, 2022	Andrea Tan	Goldman Sachs	$70.00	$56.79	23.26%	1165.82%

Row per page

Go to

The latest Kodiak Sciences stock forecast, released on Sep 24, 2024 by Andrea Tan from Goldman Sachs, set a price target of $2.00, which represents a -17.78% decrease from the stock price at the time of the forecast ($2.43), and a -63.83% decrease from KOD last price ($5.53).

Kodiak Sciences Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	1
Avg Price Target	-	$2.00	$2.00
Last Closing Price	$5.53	$5.53	$5.53
Upside/Downside	-100.00%	-63.83%	-63.83%

In the current month, the average price target of Kodiak Sciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Kodiak Sciences's last price of $5.53. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 24, 2024	Goldman Sachs	Sell	Sell	Hold
Sep 05, 2024	H.C. Wainwright	-	Neutral	Initialise
Apr 04, 2024	UBS	Neutral	Neutral	Hold
Apr 01, 2024	Barclays	Underweight	Underweight	Hold
Jul 24, 2023	Raymond James	-	Outperform	Initialise
Jul 24, 2023	Citigroup	Neutral	Overweight	Initialise
Jul 24, 2023	RBC Capital	-	Outperform	Initialise
Jul 24, 2023	Barclays	-	Equal-Weight	Initialise
Jul 24, 2023	Goldman Sachs	Neutral	Buy	Initialise
Nov 14, 2022	Morgan Stanley	Equal-Weight	Equal-Weight	Hold

Row per page

Go to

Kodiak Sciences's last stock rating was published by Goldman Sachs on Sep 24, 2024. The company gave KOD a "Sell" rating, the same as its previous rate.

Kodiak Sciences Financial Forecast

Kodiak Sciences Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 20	Mar 19
Revenue	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	$408.04K	$10.57K
High Forecast	-	-	-	-	-	-	-	$489.64K	$12.68K
Low Forecast	-	-	-	-	-	-	-	$326.43K	$8.46K
# Analysts	-	-	-	-	-	-	-	16	14
Surprise %	-	-	-	-	-	-	-	-	-

Kodiak Sciences's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. KOD's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Kodiak Sciences EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 20	Mar 19
# Analysts	-	-	-	-	-	-	-	16	14
EBITDA	-	-	-	-	-	-	-	$-24.17M	$-7.85M
Avg Forecast	-	-	-	-	-	-	-	$-21.07M	$-10.74M
High Forecast	-	-	-	-	-	-	-	$-16.86M	$-8.59M
Low Forecast	-	-	-	-	-	-	-	$-25.28M	$-12.89M
Surprise %	-	-	-	-	-	-	-	1.15%	0.73%

undefined analysts predict KOD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Kodiak Sciences's previous annual EBITDA (undefined) of $NaN.

Kodiak Sciences Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 20	Mar 19
# Analysts	-	-	-	-	-	-	-	16	14
Net Income	-	-	-	-	-	-	-	$-24.39M	$-7.98M
Avg Forecast	$-49.99M	$-58.14M	$-61.03M	$-55.25M	$-48.17M	$-47.60M	$-45.80M	$-20.15M	$-10.29M
High Forecast	$-49.99M	$-58.14M	$-61.03M	$-52.03M	$-43.35M	$-47.60M	$-45.80M	$-16.12M	$-8.23M
Low Forecast	$-49.99M	$-58.14M	$-61.03M	$-57.82M	$-51.38M	$-47.60M	$-45.80M	$-24.18M	$-12.35M
Surprise %	-	-	-	-	-	-	-	1.21%	0.78%

Kodiak Sciences's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. KOD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Kodiak Sciences SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 20	Mar 19
# Analysts	-	-	-	-	-	-	-	16	14
SG&A	-	-	-	-	-	-	-	$5.55M	$2.74M
Avg Forecast	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-

Kodiak Sciences's average Quarter SG&A projection for Jun 24 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to KOD last annual SG&A of $5.55M (Mar 20).

Kodiak Sciences EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 20	Mar 19
# Analysts	-	-	-	-	-	-	-	16	14
EPS	-	-	-	-	-	-	-	$-0.54	$-0.21
Avg Forecast	$-0.95	$-1.10	$-1.16	$-1.05	$-0.92	$-0.90	$-0.87	$-0.47	$-0.37
High Forecast	$-0.95	$-1.10	$-1.16	$-0.99	$-0.82	$-0.90	$-0.87	$-0.47	$-0.37
Low Forecast	$-0.95	$-1.10	$-1.16	$-1.10	$-0.98	$-0.90	$-0.87	$-0.47	$-0.37
Surprise %	-	-	-	-	-	-	-	1.16%	0.57%

According to undefined Wall Street analysts, Kodiak Sciences's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to KOD previous annual EPS of $NaN (undefined).

Kodiak Sciences Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
RVPH	Reviva Pharmaceuticals	$1.13	$10.00	784.96%	Buy
SPRO	Spero Therapeutics	$1.18	$10.00	747.46%	Buy
CTMX	CytomX Therapeutics	$0.91	$5.73	529.67%	Buy
CKPT	Checkpoint Therapeutics	$3.43	$20.00	483.09%	Buy
KOD	Kodiak Sciences	$5.53	$31.60	471.43%	Buy
GOSS	Gossamer Bio	$0.74	$3.75	406.76%	Buy
BMEA	Biomea Fusion	$6.53	$22.75	248.39%	Buy
TIL	Instil Bio	$26.50	$78.25	195.28%	Hold
FIXX	Q32 Bio	$0.93	$2.70	190.32%	Buy
STOK	Stoke Therapeutics	$12.03	$30.60	154.36%	Buy
ASMB	Assembly Biosciences	$16.14	$35.50	119.95%	Buy
AKRO	Akero Therapeutics	$28.09	$46.00	63.76%	Buy
SRPT	Sarepta Therapeutics	$104.54	$169.06	61.72%	Buy
MDGL	Madrigal Pharmaceuticals	$288.58	$315.75	9.42%	Buy

KOD Forecast FAQ

Is Kodiak Sciences a good buy?

Yes, according to 9 Wall Street analysts, Kodiak Sciences (KOD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 44.44% of KOD's total ratings.

What is KOD's price target?

Kodiak Sciences (KOD) average price target is $31.6 with a range of $2 to $114, implying a 471.43% from its last price of $5.53. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Kodiak Sciences stock go up soon?

According to Wall Street analysts' prediction for KOD stock, the company can go up by 471.43% (from the last price of $5.53 to the average price target of $31.6), up by 1961.48% based on the highest stock price target, and down by -63.83% based on the lowest stock price target.

Can Kodiak Sciences stock reach $8?

KOD's average twelve months analyst stock price target of $31.6 supports the claim that Kodiak Sciences can reach $8 in the near future.

What are Kodiak Sciences's analysts' financial forecasts?

Kodiak Sciences's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-142M (high $-137M, low $-145M), average SG&A $0 (high $0, low $0), and average EPS is $-2.692 (high $-2.6, low $-2.753). KOD's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-224M (high $-221M, low $-227M), average SG&A $0 (high $0, low $0), and average EPS is $-4.265 (high $-4.204, low $-4.314).